Most a short while ago, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger and would not activate a second